Form 4: Nuvalent CEO James Porter Executes Pre-Planned Stock Sales Totaling Over $2 Million

Nuvalent, Inc.'s President and CEO, James Richard Porter, reported the exercise of stock options and subsequent sale of Class A Common Stock totaling over $2 million, all conducted under a pre-arranged Rule 10b5-1 trading plan.

Summary

• James Richard Porter, President and CEO, and a Director of Nuvalent, Inc. (NUVL), filed a Form 4 detailing recent transactions.
• On June 16, 2025, Mr. Porter exercised stock options to acquire 27,000 shares of Class A Common Stock at an exercise price of $27.85 per share.
• Concurrently, Mr. Porter sold a total of 27,000 shares of Class A Common Stock in multiple transactions on June 16, 2025.
• The sales included 15,199 shares at a weighted average price of $76.66 (ranging from $76.07 to $77.05), 11,601 shares at a weighted average price of $77.26 (ranging from $77.07 to $77.67), and 200 shares at a weighted average price of $78.22 (ranging from $78.17 to $78.28).
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Porter on April 2, 2024.
• Following these transactions, Mr. Porter's direct beneficial ownership of Class A Common Stock stands at 249,062 shares.
• The stock options exercised were part of a grant where shares vested or shall vest over four years following January 6, 2023, in equal monthly installments, subject to continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the fact that these transactions were conducted under a pre-arranged Rule 10b5-1 plan mitigates concerns about the insider reacting to adverse non-public information. The profitable nature of the transactions for the insider is a positive for the individual.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new negative information.
• The sale prices for the Class A Common Stock were significantly higher than the option exercise price, indicating a profitable transaction for the insider.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake in the company.

Future Outlook

This document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook, as it is solely focused on insider trading activities.

Industry Context

This Form 4 filing is specific to an individual's equity transactions and does not provide information related to broader industry trends or competitive landscape. It reflects a common practice among executives to manage their equity holdings through pre-planned trading arrangements.

Related Party Transactions

• The reported transactions involve the President and CEO of Nuvalent, Inc., James Richard Porter, exercising stock options and selling company shares, which are considered insider transactions.

Stakeholder Impact

• Shareholders may observe a reduction in the direct equity stake of a key executive, which could lead to varied interpretations regarding management's long-term commitment, although the 10b5-1 plan mitigates immediate concerns.
• Employees are not directly impacted by these specific transactions, but executive stock sales can sometimes influence overall company morale or perception.

Next Steps

• The remaining unvested shares underlying the exercised option will continue to vest over the four years following January 6, 2023, in equal monthly installments, subject to continued service to Nuvalent, Inc.

Key Dates

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Rule 10b5-1 Plan, CEO, Director, Equity Transactions